Physician
Good Samaritan Hospital Physician Services, INC
Good Samaritan Hospital Physician Services, INC was paid $9.81M by Medicaid between Jan 2018 and Dec 2024, across 111 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.
33Billing provider infoGOOD SAMARITAN HOSPITAL PHYSICIAN SERVICES, INC
VINCENNES, IN 47591
VINCENNES, IN 47591
33aNPI1649432071assigned 06/26/2008
33bProvider typeHematology & Oncology Physician
28Total paid$9.81M
24GClaims276,549
24DCodes billed111
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Indiana
Rank by total paid#1 of 26
Median peer was paid$47K
This provider vs. median207×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 37,113 | $453K | |
| 2019 | 36,699 | $1.22M | |
| 2020 | 33,396 | $1.27M | |
| 2021 | 46,288 | $1.84M | |
| 2022 | 44,292 | $1.81M | |
| 2023 | 45,689 | $1.86M | |
| 2024incomplete | 33,072 | $1.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 47% | 82,275 | 70,838 | $4.60M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 67,513 | 58,363 | $2.92M |
| 59426 | 3.3% | 4,179 | 1,751 | $324K | |
| 59425 | 3.2% | 4,823 | 3,557 | $319K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 10,176 | 9,356 | $225K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.4% | 2,748 | 2,527 | $135K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 1.3% | 14,552 | 12,074 | $123K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 8,267 | 3,915 | $115K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.1% | 24,795 | 20,960 | $108K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 8,793 | 7,982 | $106K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,998 | 2,752 | $87K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,341 | 1,230 | $83K |
99 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,086 | $75K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 2,835 | $58K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 739 | $57K |
| 20610 | <1% | 1,847 | $45K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,771 | $42K |
| 87428 | <1% | 1,430 | $39K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 437 | $29K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 745 | $23K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 257 | $22K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 990 | $20K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 229 | $20K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 311 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 907 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,042 | $14K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 464 | $14K |
| G0127 | Trimming of dystrophic nails, any number | <1% | 2,440 | $13K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 132 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,679 | $12K |
| 90686 | <1% | 1,197 | $11K | |
| 80305 | <1% | 1,283 | $9K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,373 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 419 | $7K |
| 94726 | <1% | 1,102 | $7K | |
| 90688 | <1% | 766 | $7K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 77 | $7K |
| 94060 | <1% | 1,004 | $6K | |
| 59430 | <1% | 34 | $6K | |
| 93016 | <1% | 555 | $5K | |
| 94729 | <1% | 1,105 | $5K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 242 | $5K |
| 95251 | <1% | 236 | $4K | |
| 87807 | <1% | 443 | $4K | |
| 93018 | <1% | 567 | $4K | |
| 11750 | <1% | 37 | $4K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 105 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,215 | $3K |
| 73630 | <1% | 188 | $3K | |
| 99205 | Prolong outpt/office vis | <1% | 27 | $3K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 115 | $3K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 40 | $2K |
| 51701 | <1% | 115 | $2K | |
| 99305 | <1% | 71 | $2K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 15 | $2K |
| G9997 | Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter | <1% | 26 | $1K |
| 90474 | <1% | 117 | $1K | |
| 0004A | <1% | 135 | $1K | |
| 00731 | <1% | 71 | $1K | |
| 90480 | <1% | 147 | $1K | |
| 0002A | <1% | 51 | $1K | |
| 76801 | <1% | 12 | $1K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 28 | $1K |
| 99460 | <1% | 12 | $917.01 | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $838.16 |
| 0003A | <1% | 139 | $821.41 | |
| 90670 | <1% | 233 | $819.46 | |
| 81025 | <1% | 261 | $757.63 | |
| 93298 | <1% | 53 | $752.97 | |
| 93458 | <1% | 14 | $743.45 | |
| 90715 | <1% | 38 | $661.95 | |
| 81001 | <1% | 463 | $652.51 | |
| 99307 | <1% | 55 | $624.38 | |
| 96127 | <1% | 164 | $589.14 | |
| 91320 | <1% | 17 | $574.36 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 94 | $535.99 |
| 93971 | <1% | 48 | $501.70 | |
| 95806 | <1% | 12 | $477.87 | |
| 81003 | <1% | 635 | $469.99 | |
| 99462 | <1% | 16 | $458.70 | |
| 0001A | <1% | 19 | $446.52 | |
| 73562 | <1% | 12 | $385.27 | |
| 90656 | <1% | 53 | $358.74 | |
| 0064A | <1% | 46 | $334.89 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 30 | $333.37 |
| 74018 | <1% | 12 | $239.16 | |
| 93244 | <1% | 12 | $225.10 | |
| 0124A | <1% | 117 | $221.40 | |
| 88142 | <1% | 46 | $219.20 | |
| 94010 | <1% | 55 | $195.29 | |
| 93272 | <1% | 13 | $191.84 | |
| 11720 | <1% | 15 | $130.33 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 361 | $91.04 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 58 | $77.45 |
| 0013A | <1% | 20 | $74.42 | |
| 0134A | <1% | 30 | $73.80 | |
| 99051 | <1% | 1,684 | $48.82 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 44 | $0.00 |
| 90633 | 0% | 29 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 18 | $0.00 |
| 90671 | 0% | 13 | $0.00 | |
| 0298T | 0% | 12 | $0.00 | |
| 3008F | 0% | 2,221 | $0.00 | |
| 90697 | 0% | 18 | $0.00 | |
| G8732 | No documentation of pain assessment, reason not given | 0% | 18 | $0.00 |
| 90680 | 0% | 107 | $0.00 | |
| 99406 | 0% | 42 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 256 | $0.00 |
| 90698 | 0% | 119 | $0.00 | |
| 90677 | 0% | 55 | $0.00 | |
| 90744 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHACKER, ADAM (CEO)
| Provider | Location | Paid |
|---|---|---|
| Good Samaritan Hospital | Vincennes, IN | $15.85M |
| Good Samaritan Hospital | Vincennes, IN | $8.79M |
| Good Samaritan Hospital Physicians Services INC | Vincennes, IN | $3.55M |
| Good Samaritan Hospital | Vincennes, IN | $144K |
| Good Samaritan Hospital | Vincennes, IN | $62K |
| Good Samaritan Hospital | Vincennes, IN | $36K |
| Good Samaritan Hospital | Vincennes, IN | $22K |
| Good Samaritan Hospital | Vincennes, IN | $8K |
| Good Samaritan Hospital | Vincennes, IN | $949.56 |
| Good Samaritan Hospital | Vincennes, IN | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.